Literature DB >> 25567522

Serum soluble levels of the transmembrane activator and calcium-modulator and cyclophilin-ligand interactor in MPO-ANCA-associated renal vasculitis.

Miho Nagai1, Kouichi Hirayama, Itaru Ebihara, Masaki Kobayashi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25567522     DOI: 10.1007/s10157-015-1080-8

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


× No keyword cloud information.
  5 in total

Review 1.  BAFF AND APRIL: a tutorial on B cell survival.

Authors:  Fabienne Mackay; Pascal Schneider; Paul Rennert; Jeffrey Browning
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS.

Authors:  J A Gross; S R Dillon; S Mudri; J Johnston; A Littau; R Roque; M Rixon; O Schou; K P Foley; H Haugen; S McMillen; K Waggie; R W Schreckhise; K Shoemaker; T Vu; M Moore; A Grossman; C H Clegg
Journal:  Immunity       Date:  2001-08       Impact factor: 31.745

3.  ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process.

Authors:  N J Holden; J M Williams; M D Morgan; A Challa; J Gordon; R J Pepper; A D Salama; L Harper; C O S Savage
Journal:  Ann Rheum Dis       Date:  2011-08-21       Impact factor: 19.103

4.  Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity.

Authors:  Miho Nagai; Kouichi Hirayama; Itaru Ebihara; Homare Shimohata; Masaki Kobayashi; Akio Koyama
Journal:  Nephron Clin Pract       Date:  2011-02-03

5.  Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial).

Authors:  David Isenberg; Caroline Gordon; Daiana Licu; Samuel Copt; Claudia Pena Rossi; David Wofsy
Journal:  Ann Rheum Dis       Date:  2014-06-20       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.